Precision diagnostics. Regenerative therapies. Ethics-first care.¹,²
Welcome to Stemwell Regenerative Medicine in Bogotá, Colombia. Our purpose is to help patients move forward with clarity, structure, and confidence through a model that integrates precision medicine and regenerative medicine, supported by science, good clinical practices, and a strong ethical foundation.¹,²
Whether you are a local patient or visiting Bogotá for medical care, our commitment is the same: a professional, warm experience—guided by rigorous clinical evaluation and thoughtful follow-up.
Why Bogotá, Colombia for medical care
Bogotá is increasingly attractive for patients seeking medical evaluation and treatment because it combines advanced healthcare capacity with strong accessibility and connectivity.³,⁹,¹⁰,¹¹
- Air connectivity and access: Bogotá’s El Dorado International Airport has been recognized as a leading hub in Latin America, supporting convenient travel for international and domestic patients.³
- Strong clinical ecosystem: Bogotá and Colombia are home to institutions recognized among leading private hospitals in Latin America, reinforcing confidence in the city’s healthcare standards.⁹
- Growing health/medical tourism demand: National media reporting highlights Colombia’s momentum in medical/health tourism and Bogotá’s role in that growth.¹⁰,¹¹
Who we are
Stemwell is a clinic-first institution. We are not centered on individual profiles; we are built around coordinated teams, standardized processes, and patient-centered decisions. Our aim is to offer:
- A structured pathway (evaluation → plan → follow-up)
- Personalized care guided by diagnostics and your goals
- Clear expectations and transparent communication aligned with best practices for responsible clinical translation.¹,²
Ethics and responsible innovation: non-negotiable
At Stemwell, ethics is a must. We believe responsible innovation means using emerging tools only when they fit within a careful clinical framework: appropriate patient selection, informed consent, quality systems, and honest claims.¹,²
This approach is especially important in rapidly evolving areas such as extracellular vesicles/exosomes, where the scientific and regulatory landscape emphasizes product classification, manufacturing controls, and compliance.⁴,⁵
We work continuously to be leaders not only in innovation, but in translational medicine megatrends—bridging credible science into real-world care responsibly and ethically.¹,²
Our approach: from precision diagnosis to personalized regenerative care
Regenerative medicine should never be “one-size-fits-all.” That’s why we start with clinical clarity.
- Precision evaluation and diagnostic clarity
We build a strong baseline through a physician-led assessment and, when appropriate, targeted diagnostic workups. This may include advanced diagnostic partners (e.g., DNA GTx) when clinically relevant.
- Regenerative medicine therapies (case-by-case, clinically indicated)
When appropriate and based on medical evaluation, our regenerative medicine options may include:
- UC-MSCs (umbilical cord–derived mesenchymal stromal/stem cells)¹,²
- Exosomes / extracellular vesicle–based products (where appropriate and aligned with applicable oversight and regulatory frameworks).⁴,⁵
- PRP (platelet-rich plasma).⁶
- Peptides (used within a medical framework and patient-specific rationale).⁷
- Other innovative therapies, selected according to your condition, goals, and eligibility.
We emphasize transparency: what is supported by evidence, what is still emerging, and what should never be overstated.¹,²
- Complementary therapies that support outcomes
When indicated, we can integrate supportive modalities such as HBOT, physical therapy/rehabilitation, shockwave therapy, and personalized recovery planning—because outcomes often depend on a complete, structured plan rather than a single intervention.⁶
Your next step
If you are considering Stemwell, we invite you to start with a conversation. Our team will help you understand what evaluations may be needed, what options may be appropriate, and how to plan efficiently—especially if you are traveling to Bogotá.
References
- International Society for Stem Cell Research (ISSCR). Guidelines for Stem Cell Research and Clinical Translation (August 2025 update, Version 1.2). ISSCR; 2025. Accessed 2026 Mar 3. (isscr.org)
- International Society for Stem Cell Research (ISSCR). Clinical Translation of Stem Cell-based Interventions. ISSCR; 2025. Accessed 2026 Mar 3. (isscr.org)
- Bogotá District (bogota.gov.co). Bogotá’s El Dorado Airport leads Latin America in passenger traffic (2024). Published Feb 7, 2025. Accessed 2026 Mar 3. (bogota.gov.co)
- Wang CK, Tsai TH, Lee CH, et al. Regulation of exosomes as biologic medicines: regulatory challenges in development and manufacturing. Clin Transl Sci. 2024. Accessed 2026 Mar 3. (pmc.ncbi.nlm.nih.gov)
- U.S. Food and Drug Administration. Warning Letter: New Life Medical Services, LLC (CBER 25-711102; dated Sept 24, 2025; posted Oct 7, 2025). FDA; 2025. Accessed 2026 Mar 3. (fda.gov)
- Rahman E, Rao P, Abu-Farsakh HN, et al. Systematic Review of Platelet-Rich Plasma in Medical and Surgical Specialties: Quality, Evaluation, Evidence, and Enforcement. J Clin Med. 2024;13(15):4571. doi:10.3390/jcm13154571.
- DeFoor MT, Dekker TJ. Injectable Therapeutic Peptides—An Adjunct to Regenerative Medicine and Sports Performance. Arthroscopy. 2025;41(2):150-152. doi:10.1016/j.arthro.2024.09.005.
- Barry J, et al. Charting the translational pathway: ISSCR best practices… Stem Cell Reports. 2026;21(2):102784. doi:10.1016/j.stemcr.2025.102784.
- Newsweek Rankings. Latin America’s Top Private Hospitals 2025. Published 2025. Accessed 2026 Mar 3. (rankings.newsweek.com)
- El Espectador. Turismo médico en Colombia: lo que necesita saber antes de elegirlo como destino. Published Jul 23, 2025. Accessed 2026 Mar 3. (elespectador.com)
- El Tiempo. A Bogotá llegan 28 extranjeros al día por turismo de salud en 2025… Published Oct 27, 2025. Accessed 2026 Mar 3. (eltiempo.com)
